Plain-English translation of NCT07676565 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →Researchers want to understand how well two types of medications—GLP-1 receptor agonists and SGLT inhibitors—work when added to insulin therapy for people with type 1 diabetes. This study will follow 300 adults over one year who have already been prescribed one of these medications by their doctor as part of their regular care. The goal is to learn whether these treatments are safe and effective when used alongside insulin.
Type 1 diabetes can be difficult to manage with insulin alone, and some people benefit from additional medications. This study will help doctors understand whether these two types of medications are truly helpful and safe for adults with type 1 diabetes, which could change how they prescribe treatments in the future.
You likely qualify if…
You likely don't qualify if…
You would continue taking the medication your doctor prescribed—nothing changes about your actual treatment. What you would do is share your continuous glucose monitor data and health information with the research team for one year. This is a registry-based study, meaning researchers collect information from your regular doctor visits and your glucose monitor rather than asking you to come to special study appointments.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
United States